BCL2L1 and neoplasm: More importantly, BCL-XL/MCL-1 co-dependent tumor cells cannot be safely targeted with the currently available inhibitors because the combination of BCL-XL and MCL-1 inhibitors causes severe tissue damage and lethality in mice [22–24].